PUBLIC CONTRACT · 2017
Aquisição de Sofosbuvir 400 Comp e Daclatasvir 60 mg Comp ao HSEIT, EPER
- Contract value
- €66,766.81
- Signed on
- 26 June 2017
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 3478608PUBLISHED SUBJECT
Aquisição de Sofosbuvir 400 Comp e Daclatasvir 60 mg Comp ao HSEIT, EPER
Parties involved
- Place of performance
- Portugal, Região Autónoma dos Açores, Angra do Heroismo
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Gilead Sciences, Lda. · Tax ID 503604704
Values and timeline
- Contract price
- €66,766.81
- Procedure base price
- €70,000.00
- Total effective price
- €66,766.81
- Publication date
- 3 July 2017
- Award date
- 26 June 2017
- Signing date
- 26 June 2017
- Performance period
- 60 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Not stated
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 20.º, alínea b) do Decreto Legislativo Regional n.º 27/2015/A, de 29.12
- Regime
- DLR n.º 27/2015/A, de 29.12
- Framework agreement
- CP 2015/41 - ACORDO QUADRO PARA FORNECIMENTO DE MEDICAMENTOS ANTI-INFECIOSOS: ANTIVÍRICOS E ANTIFÚNGICOS ÀS INSTITUIÇÕES E SERVIÇOS DO SERVIÇO NACIONAL DE SAÚDE
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 2819234
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.